Press Releases :: ContraFect Corporation (CFRX)

Press Releases

Investors & Media

ContraFect to Present at 2017 Cantor Fitzgerald Global Healthcare Conference

September 13, 2017

ContraFect to Present at 2017 World Antimicrobial Resistance Congress

September 11, 2017

ContraFect Announces Second Quarter 2017 Financial Results

August 9, 2017

ContraFect Corporation Announces Issuance of Patent for Novel Approach to Treat Influenza Using Inhaled Antibodies

August 3, 2017

ContraFect Corporation Prices $40 Million Public Offering of Common Stock and Warrants

July 20, 2017

ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants

July 19, 2017

ContraFect to Present New Clinical and Microbiological Data on CF-301 at ASM Microbe 2017

June 1, 2017

ContraFect Chairman Steven C. Gilman Returns from Temporary Medical Leave

May 30, 2017

ContraFect Announces Initiation of Phase 2 Study Evaluating CF-301 in Patients with Staphylococcus aureus Bacteremia

May 25, 2017

ContraFect Announces First Quarter 2017 Financial Results

May 8, 2017